Antithrombotic therapy for venous thromboembolic disease.
Hyers
T M
TM
Hull
R D
RD
Weg
J G
JG
D000925:Anticoagulants / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011655:Pulmonary Embolism / Q000628:therapy; D012307:Risk Factors; D013923:Thromboembolism / Q000628:therapy; D015912:Thrombolytic Therapy / Q000379:methods*; D013924:Thrombophlebitis / Q000188:drug therapy* / Q000453:epidemiology
D000925:Anticoagulants; D005343:Fibrinolytic Agents